Evidence map›Paper›PMID 37963868›Full record

ArticleNature communications2023

Clinically relevant antibiotic resistance genes are linked to a limited set of taxa within gut microbiome worldwide.

Peter J Diebold, Matthew W Rhee, Qiaojuan Shi, Nguyen Vinh Trung, Fayaz Umrani, Sheraz Ahmed, Vandana Kulkarni, Prasad Deshpande, Mallika Alexander, Ngo Thi Hoa and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Molecular Insights into Carbapenem Resistance inInternational journal of molecular sciences · 2026
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Peter J DieboldMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
Matthew W RheeMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.ORCID 0009-0007-5072-8496
Qiaojuan ShiMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
Nguyen Vinh TrungOxford University Clinical Research Unit (OUCRU) in Ho Chi Minh City, Ho Chi Minh city, Viet Nam.
Fayaz UmraniAga Khan University, Karachi, Pakistan.
Sheraz AhmedAga Khan University, Karachi, Pakistan.
Vandana KulkarniJohns Hopkins University Clinical Trials Unit, Byramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
Prasad DeshpandeJohns Hopkins University Clinical Trials Unit, Byramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
Mallika AlexanderJohns Hopkins University Clinical Trials Unit, Byramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.ORCID 0000-0001-9332-7915
Ngo Thi HoaOxford University Clinical Research Unit (OUCRU) in Ho Chi Minh City, Ho Chi Minh city, Viet Nam.ORCID 0000-0001-9320-4050
Nicholas A ChristakisYale University, New Haven, CT, USA.ORCID 0000-0001-5547-1086
Najeeha Talat IqbalAga Khan University, Karachi, Pakistan.
Syed Asad AliAga Khan University, Karachi, Pakistan.ORCID 0000-0001-5274-7665
Jyoti S MathadWeill Cornell Medicine, New York, NY, USA.
Ilana L BritoMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA. ibrito@cornell.edu.ORCID 0000-0002-2250-3480
Cornell University · USAga Khan University · PKJohns Hopkins University · USOxford University Clinical Research Unit · VNPham Ngoc Thach University of Medicine · VNYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantationR01AI151059 · NIAID · CORNELL UNIVERSITY · PI DADHANIA, DARSHANA, DE VLAMINCK, IWIJN · 2020 to 2024
$3.4M
Systems-Level Perspectives of Horizontal Gene Transfer Within the Human MicrobiomeDP2HL141007 · NHLBI · CORNELL UNIVERSITY · PI BRITO, ILANA LAUREN · 2017 to 2020
$2.6M
Medical Research Council MR/R002762/1NCATS NIH HHS UL1 TR001863NHLBI NIH HHS DP2 HL141007NIAID NIH HHS R01 AI151059
6 · The paper itself

Abstract

The acquisition of antimicrobial resistance (AR) genes has rendered important pathogens nearly or fully unresponsive to antibiotics. It has been suggested that pathogens acquire AR traits from the gut microbiota, which collectively serve as a global reservoir for AR genes conferring resistance to all classes of antibiotics. However, only a subset of AR genes confers resistance to clinically relevant antibiotics, and, although these AR gene profiles are well-characterized for common pathogens, less is known about their taxonomic associations and transfer potential within diverse members of the gut microbiota. We examined a collection of 14,850 human metagenomes and 1666 environmental metagenomes from 33 countries, in addition to nearly 600,000 isolate genomes, to gain insight into the global prevalence and taxonomic range of clinically relevant AR genes. We find that several of the most concerning AR genes, such as those encoding the cephalosporinase CTX-M and carbapenemases KPC, IMP, NDM, and VIM, remain taxonomically restricted to Proteobacteria. Even cfiA, the most common carbapenemase gene within the human gut microbiome, remains tightly restricted to Bacteroides, despite being found on a mobilizable plasmid. We confirmed these findings in gut microbiome samples from India, Honduras, Pakistan, and Vietnam, using a high-sensitivity single-cell fusion PCR approach. Focusing on a set of genes encoding carbapenemases and cephalosporinases, thus far restricted to Bacteroides species, we find that few mutations are required for efficacy in a different phylum, raising the question of why these genes have not spread more widely. Overall, these data suggest that globally prevalent, clinically relevant AR genes have not yet established themselves across diverse commensal gut microbiota.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaAnti-Bacterial AgentsDrug Resistance, MicrobialGenes, BacterialHumansAnti-Bacterial Agents

Identifiers

PMID37963868
PMCPMC10645880
OpenAlexW4388667537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.